As we approach the end of the first quarter of 2020, investment fund managers and investors in non-traded or infrequently traded debt and equity investments have a fiduciary duty to report independent and credible fair value information to investors and stakeholders. This process is complicated by the rapidly changing global health situation due to the coronavirus (COVID-19). Given the volatility demonstrated in the public markets and the unknown ultimate impact of COVID-19, using informed judgment to estimate the fair value of investments will require even more thought and analysis.
Please join us for a discussion on how best to reflect the impact of COVID-19 on estimating and reporting fair value for the March 31, 2020 quarter end.
Schedule
Topics
Speakers
Our valuation experts provide valuation services for financial reporting, tax, investment and risk management purposes.
Kroll specializes in assisting clients with the valuation of alternative investments, specifically securities and positions for which there are no "active market" quotations.
Heightened regulatory concerns and vigilance, together with increased investor scrutiny, have led to increased demand for independent expert advice.